TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 80 filers reported holding TERNS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $274 | -88.1% | 54,327 | -79.3% | 0.00% | -100.0% |
| Q2 2023 | $2,301 | -63.7% | 262,918 | -50.8% | 0.00% | -66.7% |
| Q1 2023 | $6,332 | +20.4% | 534,760 | +3.5% | 0.00% | +50.0% |
| Q4 2022 | $5,261 | -99.9% | 516,739 | -21.6% | 0.00% | -50.0% |
| Q3 2022 | $3,882,000 | +11663.6% | 659,098 | +4921.7% | 0.00% | – |
| Q2 2022 | $33,000 | -28.3% | 13,125 | -14.5% | 0.00% | – |
| Q1 2022 | $46,000 | – | 15,352 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |